Oncology
A section of Journal of Clinical Medicine (ISSN 2077-0383).
Section Information
Recent advances in molecular technologies and diagnostics have provided many tools for effective cancer therapy and increased patient survival rates. The oncology section facilitates the translation of experimental results into clinical settings, taking research findings from the “bench to bedside and back”. This translation is fundamentally important for advancements in cancer prevention, diagnosis, and effective treatment.
The oncology section welcomes original research articles and reviews on genetic/epigenetic alterations, biomarkers predictive of response to oncologic therapies, in human and in vitro studies of new pharmaceutical formulations, cancer metabolism, angiogenesis and metastasis, infectious agents related cancer, cancer immunology and immunotherapies, epidemiology, clinical trials, and controversial themes in oncology.
Section Areas
Hot research topics include, but are not limited to the following:
- Cancer biomarkers
- Cancer diagnosis
- Cancer epidemiology
- Cancer genetics and epigenetics
- Cancer metabolism
- Cancer prevention
- Cancer cells migration and metastasis
- Clinical trials
- Drug resistance
- Infectious agents related cancers
- Novel therapeutic targets and immunotherapy
- Precision medicine
- Prevention and early detection
- Rare tumours
- Signal transduction
- Tumor heterogeneity
- Tumor microenvironment
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Innovations, Biomarkers, and Challenges in Cancer Immunotherapy (Deadline: 10 May 2026)
- Gastroesophageal Cancer: Advances in Clinical Diagnosis and Management (Deadline: 15 May 2026)
- Non-Small Cell Lung Cancer (NSCLC): Recent Advances in Clinical Diagnosis and Treatment (Deadline: 25 May 2026)
- High-Risk Neuroblastoma and Rhabdoid Tumors: New Clinical Insights and Challenges (Second Edition) (Deadline: 25 May 2026)
- Clinical Advances in Cancer Imaging (Deadline: 15 June 2026)
- New Advances in Stereotactic Radiosurgery (Deadline: 18 June 2026)
- The Changing Landscape of Biliary Cancers (Deadline: 20 June 2026)
- Advances in Clinical Approaches to Breast Cancer Diagnosis and Treatment (Deadline: 20 June 2026)
- Clinical Research Advances in Gynecologic Oncology (Deadline: 20 June 2026)
- Cancer Stem Cells and Cellular Therapies in Cancer: Advances and Clinical Prospects (Deadline: 20 June 2026)
- Gynecologic Cancers: Integrating Established Standards and Innovative Approaches (Deadline: 10 July 2026)
- Clinical Diagnosis and Treatment in Oncology: Radiotherapy and Imaging Analysis (Deadline: 20 July 2026)
- Diagnosis, Treatment and Prognosis of Head and Neck Cancer (Deadline: 20 July 2026)
- Insights on Cancer Diagnosis, Treatment and Side Effects Management (Deadline: 20 July 2026)
- Colorectal Cancer: Early Detection, Treatment Advances and Patient Outcomes (Deadline: 20 July 2026)
- Advances and Perspectives in Cancer Diagnostics and Treatment (Deadline: 20 July 2026)
- Precision Therapies in Multiple Myeloma Management (Deadline: 20 July 2026)
- Rewriting Metastatic Colorectal Cancer Management: Innovative Frontiers in Clinical Diagnosis and Personalized Oncology (Deadline: 24 July 2026)
- Recent Advances in Immunotherapy of Cancer (Deadline: 20 August 2026)
- Breaking the Barrier: Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) (Deadline: 20 August 2026)
- Clinical Advances in Diagnosis and Treatment of Metastatic Spinal Tumor (Deadline: 20 August 2026)
- Cancer Immunotherapy: Recent Advances and Clinical Challenges (Deadline: 20 August 2026)
- Surgical Oncology: Clinical Application of Translational Medicine (Deadline: 20 August 2026)
- Early Palliative Care for Patients with Advanced Cancer (Deadline: 25 August 2026)
- Gastrointestinal Cancer: Outcomes and Therapeutic Management—2nd Edition (Deadline: 25 August 2026)
- Tumor Microenvironment—Current Status and Therapeutic Targets (Deadline: 28 August 2026)
- Photodynamic Therapy for Cancers: Clinical Advances and Prospects (Deadline: 10 September 2026)
- Current Concepts in Prostate Cancer: From Early Detection to Therapeutic Innovations (Deadline: 20 September 2026)
- Supportive Care Across Proton and Photon Radiotherapy: Access, Challenges, and Solutions (Deadline: 20 September 2026)
- Current Advances in Artificial Intelligence in Oral Cancer Research, Early Diagnosis, and Personalized Therapy (Deadline: 20 September 2026)
- Emerging Radiotherapy Technologies and Trends (Deadline: 20 September 2026)
- Advances and Challenges in Colorectal Cancer (Deadline: 20 September 2026)
- Breast Cancer: Advances in Clinical and Personalized Practices (Deadline: 25 September 2026)
- Thoracic Radiochemoimmunotherapy for Non-Small Cell Lung Cancer (NSCLC): Evolving Techniques and Clinical Applications (Deadline: 5 October 2026)
- Comprehensive Approaches in Gastrointestinal Oncology: Focus on Colorectal, Gastric, and Pancreatic Cancer Treatment (Deadline: 15 October 2026)
- New Insights into Breast Neoplasms: Prevention, Multidisciplinary Management and Beyond the Core Team (Deadline: 20 October 2026)
- Contemporary Advances in Diagnosis and Therapeutic Management of Head and Neck Cancer (Deadline: 25 October 2026)
- Sarcoma—Clinical Updates: 2nd Edition (Deadline: 25 October 2026)
- Clinical Update in Bone and Soft Tissue Sarcomas (Deadline: 25 October 2026)
- Advances in the Diagnosis and Treatment of Skin Cancer (Deadline: 25 October 2026)
- Colorectal Cancer: Screening, Diagnosis and Treatment (Deadline: 20 November 2026)
- Recent Advances in the Diagnosis and Treatment of Breast Cancer (Deadline: 20 November 2026)
- Advances in Immunotherapy for Tumors: From Biomarkers to Novel Therapeutics and Exosome-Mediated Modulation (Deadline: 25 November 2026)
- Novel Biomarkers and Treatment Strategies for Gastrointestinal Malignancies: From the Bench to the Bedside (Deadline: 26 November 2026)
- Towards Precision Oncology in Bone Sarcomas: New Insights into Osteosarcoma and Chondrosarcoma (Deadline: 20 January 2027)